LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Cardlytics, Inc. ("Cardlytics" or "the Company") (NASDAQ:CDLX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by […]
LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Micron Technology, Inc. ("Micron" or "the Company") (NASDAQ:MU) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder
LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ESSA Pharma Inc. ("ESSA" or "the Company") (NASDAQ:EPIX) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder
LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of XPLR Infrastructure, LP ("XPLR" or "the Company") (NYSE:NEP) for violations of the securities laws. The investigation focuses on whether the Company issued false
LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Arconic Corporation ("Arconic" or "the Company") (ARNC) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by
LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Grocery Outlet Holding Corp. ("Grocery Outlet" or "the Company") (NASDAQ:GO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5
Wingderm® once again participated in IMCAS World Congress from 30th January to 1st February 2025, presenting its core devices and newest platforms. The showcased devices included Lasermach Duo, Lasermach, Renuva, Mesoskin, and and other advanced solutions. https://mma.prnewswire.com/media/2610981/Wingderm__at_IMCAS.jpg Wingderm®'s Booth Bustling with VisitorsWingderm®'s booth was constantly bustling with visitors, drawn by professional device presentations and in-depth
NEW YORK, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sprout Social, Inc. ("Sprout" or "the Company") (NASDAQ:SPT). Investors who purchased Sprout securities prior to November 3, 2021, and continue to hold to the present, are encouraged to obtain additional
NEW YORK, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional
NEW YORK CITY, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elanco Animal Health Incorporated ("Elanco" or "the Company") (NYSE:ELAN). Investors who purchased Elanco securities prior to November 7, 2023, and continue to hold to the present, are encouraged to